Urovalve, Inc.

Newark, NJ 07103

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $1.36MM
First Award Date 12/10/04
Most Recent Award Date 09/01/11

Key Personnel

Last Name Name Awards Contact
Davis Phillip J Davis 1
Homan Harvey D Homan 3
Winegar Thomas William Winegar 1

5 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 09/01/11 - 08/31/12

DESCRIPTION (provided by applicant): Urovalve, Inc. is developing a novel, patent pending insertion device preassembled to a Foley catheter. The Surinate(R) Foley Catheter with Inserter System is designed to enable skilled healthcare professionals such as urologists and experienced urological nurses to insert smaller, softer, more comfortable Fo...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-120
Budget: 12/30/09 - 12/29/10

DESCRIPTION (provided by applicant): The objectives of this proposed Phase II SBIR project are to refine the SurinateTM disposable valved intraurethral catheter to make it easier for the patient to operate, more reliable and easier to insert and extract than the prototype that was tested in the Phase I SBIR feasibility study. The effectiveness a...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-20
Budget: 06/01/08 - 05/31/10

DESCRIPTION (provided by applicant): The objectives of this proposed Phase II SBIR project are to refine the SurinateTM disposable valved intraurethral catheter to make it easier for the patient to operate, more reliable and easier to insert and extract than the prototype that was tested in the Phase I SBIR feasibility study. The effectiveness a...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-20
Budget: 06/20/07 - 05/31/08

DESCRIPTION (provided by applicant): The objectives of this proposed Phase II SBIR project are to refine the SurinateTM disposable valved intraurethral catheter to make it easier for the patient to operate, more reliable and easier to insert and extract than the prototype that was tested in the Phase I SBIR feasibility study. The effectiveness a...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 12/10/04 - 11/30/05

DESCRIPTION (provided by applicant): Urovalve, Inc. has developed a user operated valved catheter to enable people with chronic urinary retention to pursue more active lives and decrease the high incidence of urinary tract infections. The device is a short silicone catheter with a malecot to retain it in the bladder and a miniature proximity val...